Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants.
Background: Existing pharmacogenetic algorithms cannot fully explain warfarin dose variability in all patients. CYP2C9*13 is an important allelic variant in the Han Chinese population. However, adjustment of warfarin dosing in CYP2C9*13 variant carriers remains unclear. To the best of our knowledge,...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 79; no. 10; pp. 1315 - 1321 |
|---|---|
| Autores principales: | , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Springer Nature
Oct2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |